Benzinga | Nov 9, 2021 11:10AM EST

Definitive Healthcare Corp. Sees Q4 Adj. EPS $0.04-$0.05 vs $0.04 Est., Sales $44M-$45M vs $43.66M Est.; Sees FY21 Adj. EPS $0.08-$0.09 vs $0.12 Est., Sales $164M-$165M vs $161.69M Est.

Business Outlook

Based on information as of November 8, 2021, the Company is issuing the following financial guidance.

Fourth Quarter 2021:

* Revenue is expected to be in the range of $44 -- $45 million, a 32% increase year over year.

* Adjusted Operating Income is expected to be in the range of $11.5 -- $12.5 million.

* Adjusted EBITDA is expected to be in the range of $12.5 -- $13.5 million.

* Adjusted Net Income is expected to be $6 -- $7 million.

* Adjusted Net Income Per Diluted Share is expected to be $0.04 -- $0.05 on approximately 148.6 million weighted-average shares outstanding.

Full Year 2021:

* Revenue is expected to be in the range of $164 -- $165 million.

* Adjusted Operating Income is expected to be in the range of $52 -- $53 million.

* Adjusted EBITDA is expected to be in the range of $55 -- $56 million.

* Adjusted Net Income is expected to be $13 -- $14 million.

* Adjusted Net Income Per Diluted Share is expected to be $0.08 -- $0.09 on approximately 148.5 million weighted-average shares outstanding.